Status and phase
Conditions
Treatments
About
This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-Participants with Masseter Muscle Hypertrophy
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
187 participants in 5 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal